Advertisement

Topics

Companies Related to "Blood Samples to Identify Biomarkers in Haploidentical Graft Recipients" [Most Relevant Company Matches] RSS

01:54 EST 19th February 2019 | BioPortfolio

Here are the most relevant search results for "Blood Samples to Identify Biomarkers in Haploidentical Graft Recipients" found in our extensive corporate database of over 50,000 company records.

Showing "Blood Samples Identify Biomarkers Haploidentical Graft Recipients" Companies 1–25 of 1,700+

Extremely Relevant

Vivomicx

We identify: real biomarkers for drug efficacy to speed up your development process Using this, you can relate true molecular effects to disease activity and the value of your biomarkers We Validate: the pharmacological identity of your NME in complex tissues in vivo, before your drug enters clinical testing the expression of your new putative targets in patient materials your biomarkers...


Relevant

ZymeQuest Incorporated

ZymeQuest, a development stage company, is the global leader in the discovery, development and commercialization of enzymatic blood conversion products for use in blood transfusion medicine. Our enzymatic blood conversion system enables the precise and permanent conversion of groups A, B and AB red blood cells to enzyme converted group O red blood cells, known as ECO red cells. ECO red cells are f...

Banyan Biomarkers, Inc.

Banyan Biomarkers is the leader in developing in vitro diagnostic products to address unmet clinical needs for the detection of traumatic brain injury. The Company is focused on developing a simple point-of-care blood test that will be used by physicians to detect the presence and severity of brain trauma and improve the medical management of head i...


nanoMR Inc.

nanoMR is an early stage life sciences company developing novel diagnostic systems for rapid and sensitive identification of pathogens in whole blood and other samples. nanoMR’s system couples immunochemistry with analytical methods such as PCR or DNA hybridization to identify bacterial and fungal infections at clinically-relevant levels. The company...

MaaT Pharma

MaaT Pharma has established the most complete approach to restoring patient-microbiome symbiosis to improve survival outcomes in life-threatening diseases. Committed to treating blood cancers and graft-versus-host disease, a serious complication of allogeneic stem cell transplantation, MaaT Pharma has already achieved proof of concept in acute myeloid leuk...

ImmunArray

Co-located in Rehovot, Israel and Richmond, Va., ImmunArray is a privately funded molecular diagnostics company dedicated to the development of novel blood-based tests that support the diagnosis and management of complex acute and chronic immune and neurodegenerative diseases. The company designs and analyzes sets of biomarkers known to be linked to a part...

TxFinder

CENTRAL NERVOUS SYSTEM DISORDERSTARGETED GENOMIC SAMPLE COLLECTIONTxFinder contracts with pharmaceutical companies, genomics companies and other biotech companies to collect targeted blood samples from individuals with CNS diseases.We can collect a large number of targeted blood samples in a short period of time. We make more than 1500 direct, unduplicated CNS patient contacts per month. Through...

NeuroPointDX

NeuroPointDX is the diagnostics division of Stemina Biomarker Discovery. Stemina is a biotechnology company based in Madison, WI and Cambridge, MA that has developed a robust and reproducible proprietary platform for identifying changes in metabolism (“biomarkers”) utilizing highly sensitive analytical equipment and its proprietary platform technology. ...

Artegraft, Inc.

Incorporated in 1993, Artegraft, Inc. offers surgeons a biological alternative to synthetic grafts. Artegraft’s natural collagen matrix has proven long-term patency advantages over ePTFE and other synthetic graft materials. Artegraft is also positioned as an alternative to a non-viable autogenous fistula. Artegraft was the first vascular graft a...

Kiadis Pharma N.V.

Kiadis Pharma is a clinical stage biopharmaceutical company focused on research, development and future commercialization of cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders. The Company believes that its innovative products have the potential to address the current risks and limitations connected with allo...

Cellestis Inc

Cellestis was formed in late 2000 to research, develop and market QuantiFERON technology products for medical diagnosis and scientific research. The QuantiFERON technology is a patented whole blood method for detecting cell mediated immune (CMI) responses using whole blood samples. This unique technology provides its users savings in time, labor and reagents compared to other methodologies of meas...

SIRAKOSS Ltd

SIRAKOSS is developing nanosynthetic graft substitutes to facilitate complete bone repair and transform patient healing. The SIRAKOSS bone graft substitutes utilise advanced and proprietary understanding of nanostructures and nanochemistry to catalyze faster bone regeneration coupled with total graft resorption. SIRAKOSS was spun out of the University of A...

SpectRx

SpectRx is engaged in the research, development, manufacturing, and marketing of products that offer less invasive and painless alternatives to blood tests currently used for infant jaundice, diabetes screening, glucose monitoring and cancer detection. The Company's products are based on proprietary biophotonic technology that can eliminate the pain and inconvenience of tissue and blood samples. B...

InnAVasc, Inc.

InnAVasc Medical, Inc. is a medical device company founded by Duke University surgeons and scientists, which designs and develops products for vascular and hemodialysis access. The Company’s first technology is an arteriovenous graft (AVG) modification that incorporates two multilayer cannulation chambers, with self-sealing technology, that are resist...

The Blood Alliance

The Blood Alliance (TBA) provides blood and blood products to more than 20 hospitals and medical facilities in 10 counties serving Northeast Florida, and portions of Georgia and South Carolina. It provides the best possible blood banking system to the regions it serves. TBA opened in 1942 and is a non-profit community blood center licensed by the FDA and accredited by the AABB. For more informatio...

Amplion Inc.

Amplion publishes BiomarkerBase™ (http://www.biomarkerbase.com), the most complete database of biomarkers in clinical use and development. BiomarkerBase™ includes every biomarker used in and FDA-approved test or drug label, and thousands of biomarkers being used and developed in clinical trials. Many of the world’s leading diagnostics and bi...

Tethys Bioscience

Tethys Bioscience was founded in 2002 by two biotechnology veterans, Mickey S. Urdea and Gregory T. Went, with an emphasis on applying new technologies and techniques to the problems of getting novel diagnostics products to market faster, more efficiently, and with less cost. he company successfully concluded its Series A funding in 2005. At that time, Michael McKenna and Mike Richey joined the co...

Cellumen, Inc.

Cellumen is a systems cell biology company that is focused on defining the functions of genes, coding and non-coding RNA's, proteins and other cellular constituents that regulate and perform the myriad of functions that define normal life and are related to specific disease processes as potential biomarkers and/or targets for drug discovery and patient profiling. Cellumen uses multiple High Conten...

ApaTech, Inc.

ApaTech is a world leader in synthetic bone graft technologies. Our mission is to provide surgeons with superior, proprietary, bone graft solutions, helping them improve clinical outcomes and patient quality of life. ApaTech was formed in 2001 with the rights to bone materials research and IP from London and Cambridge Universities. The company retains pipeline agreements with founding inventors, i...

Abaxis, Inc.

Abaxis develops, manufactures and markets portable blood analysis systems for use in any veterinary or human patient-care setting to provide clinicians with rapid blood constituent measurements. The system consists of a compact, 5.1 kilogram (11.2 pounds), portable analyzer and a series of single-use plastic discs, called reagent discs that contain all the chemicals required to perform a panel of...

Finnish Red Cross Blood Service

The Finnish Red Cross Blood Service is the nationwide blood service provider in Finland. The Blood Service collects blood and processes it into such preparations and medicinal products as hospitals require for treating patients. The Blood Service is a financially and operationally independent section of the Finnish Red Cross. Each year 300 000 bags of blood are donated in Finland, with up to 60 00...

Haemonetics

For more than 30 years, Haemonetics has been a global leader in blood processing technology. The Company has two families of products:Donor Products - These products are marketed to the blood donation industry and include products that automate the blood donation process, automate the processing of blood, support pathogen inactivation and bacterial detection of blood, and test blood hematocrit.Pat...

General Activation Analysis

General Activation Analysis, Inc.tests samples for outside customers. Every year hundreds of companies, from all parts of the world, send samples for elemental determinations. Some of the more interesting samples include bullets from homicide cases, parts from the Space Shuttle, hair to determine Arsenic poisoning, paint from old paintings and very, very small glass balls used in fusion experiment...

GeneOS Ltd

GeneOS improves patient care by better understanding of current health care system and pharmaceutical usage and economics. Our understanding can be used to help identify optimum treatments for individuals, help pharmaceutical companies accelerate drug discovery and to validate new molecular diagnostics. GeneOS leverages Finland's healthcare system, which is regarded as one of the best in the world...

INTERNATIONAL A BIOMET COMPANY

Interpore Cross International is part of the Biomet Companies. Biomet and Interpore Cross are on the cutting edge of technology in the orthopedic biomaterials market. Our focus is developing and providing truly innovative products, which meet the rapidly expanding needs of orthopedic surgeons both today and in the future.Pro OsteonOur Pro Osteon resorbable bone graft material is derived from an ab...


More From BioPortfolio on "Blood Samples to Identify Biomarkers in Haploidentical Graft Recipients"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks